Eli Lilly's stock surges toward a 5th straight record after an earnings beat and upbeat outlook : vimarsana.com

U.S. prices for Lilly’s drugs climbed 27%, driven by diabetes treatment Mounjaro, while prices outside the U.S. fell.

Related Keywords

, Eli Lilly , Article Normal , Weightloss , Diabetes , Pharmaceuticals , Machinery , Agricultural Machinery , Health Care , Specialized Drugs Medications , Hormone Products , Industrial Goods , Diabetes Drugs , Financial Performance , Earnings , Earnings Surprises , Share Price Movement Disruptions , Corporate Industrial News , Political General News , Health , Medical Conditions , Equity Markets , Commodity Financial Market News , Content Types , Factiva Filters , C Amp Ampe Exclusion Filter , C Amp Ampe Industry News Filter , Eli Lilly Amp Co , Lly , Spx , Health Care Select Sector Spdr Etf , Xlv , S Amp Ampp 500 Index , Share Price Movement , Disruptions , Corporate , Industrial News , Political , General News , Commodity , Financial Market News , Specialized Drugs , Medications ,